Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
This video looks at highlights from the IQVIA Institute report on Global Trends in R&D 2023, including new drug approvals and the industry's pipeline of medicines in clinical development in addition to clinical trial activity, clinical development productivity and productivity enablers, efforts to accelerate the innovation cycle, and R&D funding and deal-making trends.
Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.
Change the model of clinical research by integrating data, expertise, analytics and technology from study design through execution to power better decisions.
Bring trials directly to patients to improve access and engagement, increase quality and shorten timelines.
See how we partner with organizations across the healthcare ecosystem, from emerging biotechnology and large pharmaceutical, to medical technology, consumer health, and more, to drive human health forward.
Accelerate the development of new therapies.
Greater visibility into the impact of treatments.
The tools and the data to keep growing.